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Abstract
MHC class I molecules present a comprehensive mixture of peptides on the cell surface for immune surveillance. The
peptides represent the intracellular protein milieu produced by translation of endogenous mRNAs. Unexpectedly, the
peptides are encoded not only in conventional AUG initiated translational reading frames but also in alternative cryptic
reading frames. Here, we analyzed how ribosomes recognize and use cryptic initiation codons in the mRNA. We find that
translation initiation complexes assemble at non-AUG codons but differ from canonical AUG initiation in response to
specific inhibitors acting within the peptidyl transferase and decoding centers of the ribosome. Thus, cryptic translation at
non-AUG start codons can utilize a distinct initiation mechanism which could be differentially regulated to provide peptides
for immune surveillance.
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Introduction
The presentation of peptides, derived from endogenously
synthesized proteins, by the major histocompatibility complex
class I molecules (MHC I) is essential for immune surveillance by
the CD8
+ T cell repertoire [1,2,3]. The peptides are produced by
the antigen processing pathway which begins with proteasomal
degradation of newly synthesized proteins and ends with
presentation of pMHC I on the cell surface [4,5,6]. Interestingly,
the peptide mixture contains proteolytic products of not only
conventional AUG initiated open-reading frames (ORFs) but also
those encoded by alternative reading frames (ARFs) with or
without AUG initiation codons called cryptic translation products
or cryptic pMHC I [1]. Although cryptic pMHC I are expressed at
low levels, they are nevertheless capable of eliciting CD8
+ T cell
responses specific for a variety of tumors, virus infected or even
normal cells (reviewed in [1,7]).
Previously, we had used T cell assays to detect cryptic pMHC I
on the cell surface and in cell extracts [8,9,10]. These
measurements showed that not only non-AUG initiation codons,
such as CUG, could be used to translate antigenic peptides, but
that the CUG codon was decoded with a leucine residue. Initiating
translation with a leucine, rather than the canonical methionine
was very unusual. Established models of translation suggest that
initiation at non-AUG start codons is mediated by the methionine
charged initiator tRNA (Met-tRNAi
Met) through ‘wobble’ inter-
actions with the anticodon [11,12]. Accordingly, the non-AUG
initiation codon, CUG should have been decoded as a methionine
residue suggesting the existence of unusual translation mechanisms
for generating cryptic pMHC I.
The display of pMHC I on the cell surface is a key mechanism
for immune surveillance of infected cells synthesizing new viral
proteins [4]. Interestingly, viruses have evolved alternate mecha-
nisms to subvert normal translational controls [13]. For example,
many viral gene products are translated using internal ribosome
entry sites (IRES) [14]. The IRES allows direct binding of
ribosomal initiation complexes to appropriate start codons without
the requirement for 59 to 39 scanning. On the other extreme, some
insect viruses do not require any known initiation factors [15,16].
The downstream capsid protein coding sequence of the Cricket
Paralysis (CrPV) or the Plautia stali intestine viruses are translated
by initiation at the non-AUG codons GCU or CAA using alanine
or glutamine residues respectively. Remarkably, the IRES
elements of these insect viruses can also function in mammalian
cells suggesting that they interact with highly conserved features of
the eukaryotic ribosome. Thus, it was possible that IRES-like
mechanisms could have been used for translating cryptic pMHC I.
Internal ribosome entry was apparently unnecessary for
translation because expression of cryptic pMHC I was inhibited
by insertion of upstream hairpin sequences [10]. Furthermore,
unlike presentation of the AUG-initiated peptide, which was
inhibited by upstream out-of-frame AUG codons, the presentation
of the CUG-initiated peptide was inhibited by upstream CUG
rather than AUG codons. This observation suggested that the
ribosomes initiating translation at CUG codons were actually
scanning for CUG codons and thus differed from conventional
ribosomes that scan for AUG initiation codons. In addition,
sodium arsenite, an inhibitor of methionine initiation [17], affected
presentation of an AUG-initiated peptide, but not a CUG peptide,
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for eukaryotic ribosomes initiating at non-AUG start codons.
Independently, a distinct set of ribosomes, termed the ‘‘immunor-
ibosome’’, has been proposed to generate peptides for presentation
by MHC I [18]. Thus, protein synthesis may not only be linked to
generation of pMHC I, but could involve novel translational
mechanisms.
Here, we analyzed the ribosomal initiation complexes that
recognize the initiation codon in mRNAs encoding a cryptic
antigenic peptide. We show that non-AUG codons, such as CUG,
engage ribosomes during the initiation step of translation.
Moreover, these complexes can be distinguished from those that
recognize conventional AUG codons by small molecule inhibitors
that affect the P site of the ribosome/tRNA initiation complex.
Results
Ribosome initiation complexes recognize a non-AUG
start codon
To characterize the molecular mechanism which permits non-
AUG start codons, such as CUG to engage ribosomes, we used the
primer extension inhibition assay called toeprinting [19] (Fig. S1).
The ribosomes are allowed to assemble on a mature mRNA
during the translation initiation step but are prevented from
translating the entire message by the elongation inhibitors
cycloheximide and sparsomycin. The location of the ribosomes
bound to the mRNA is then determined by extending a [
32P]-
labeled complementary 39 primer with reverse transcriptase (RT)
and the RT products are visualized after fractionating by gel-
electrophoresis. The size of the RT products, measured at a single
nucleotide resolution by comparison with sequencing reactions run
on the same gel, indicates the distance traversed by RT on the
mRNA.
We synthesized mRNAs from the same cDNA constructs used
earlier to generate pMHC I in transfected cells (Fig. 1A). Cells
translating the LYL8 (LTFNYRNL) peptide derived from the H60
histocompatibility gene, or its analog MYL8 (MTFNYRNL),
present the peptide-K
b MHC I complex on the cell surface [8,9].
This gene has been used as a model to study cryptic translation
because the AUG or the CUG initiation codons can be decoded as
Met or Leu residues to yield Met-YL8 (AUG[YL8]) or the Leu-
YL8 (CUG[YL8]) peptides (Fig. 1A). When the AUG[YL8]
mRNA was used as a template in the absence of ribosomes, a
strong band representing the full-length cDNA fragment as well as
Figure 1. Ribosome initiation complexes recognize cryptic CUG start codons. (A) The mRNA sequences of the AUG[YL8] and CUG[YL8]
constructs used for toeprinting differ at a single nucleotide in the initiation codon (boxed). The amino acid sequence encoded by AUG[YL8]
(MTFNYRNL, MYL8) or the CUG[YL8] (LYL8) are shown above and below the nucleotide sequences respectively. (B) Toeprinting analysis on AUG[YL8]
and CUG[YL8] mRNAs using rabbit reticulocyte lysate as the ribosome source (see methods for experimental details). A band at +15–17 nucleotides
downstream of the A of the AUG codon (boxed) is the toeprint and represents the leading edge of ribosomal initiation complexes at either the AUG
or the cryptic CUG start codons. The bands above the toeprint bands (,12 nt from the start codon) are non-specific because they were unaffected by
translation initiation inhibitors. Sequencing lanes shown are for the CUG[YL8] mRNA. The data shown are representative from 5 independent
toeprinting experiments. (C) Toeprint intensity of the AUG and CUG bands from (B) is shown in arbitrary Phosphoimager units (AU). On average, the
CUG toeprint represents 18–25% of the intensity of the AUG toeprint.
doi:10.1371/journal.pone.0003460.g001
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smaller fragments are likely due to secondary structures in the
mRNA template which inhibit the progress of RT at the lower
30uC temperature used in this assay. In the presence of rabbit
reticulocyte lysate (RRL), used as a source of ribosomes, and the
elongation inhibitor cycloheximide, the intensity of the full-length
fragment markedly decreased and new bands appeared (lane 2).
The size of these RT products was determined by comparison with
the sequencing reactions (lanes 9–12)a s+15–17 nucleotides
downstream of the AUG codon where the first nucleotide of the
AUG triplet is +1. Another larger band terminating at +12
nucleotides downstream of AUG was also reproducibly observed
which is likely to be non-specific because it was unaffected by
translation initiation inhibitors (see below). The intensity of these
bands was further increased when sparsomycin, another elonga-
tion inhibitor, was also added to the reaction (compare lanes 2
and 3). These bands represent ribosomes bound to the mRNA
because they were not detected when EDTA was added to disrupt
ribosomes by chelating Mg
2+ ions (lane 4). We conclude that
ribosomal initiation complexes can be observed at the conven-
tional AUG codon by toeprinting. Furthermore, these initiation
complexes are likely to include the small 40S ribosomal subunit
which contains initiator Met-tRNAi
Met to provide specificity for
the AUG initiation codon. Furthermore, because both cyclohex-
imide and sparsomycin inhibit elongation by binding to the 60S
ribosomal subunit indicates that these complexes also contain the
large 60S ribosomal subunit.
The CUG[YL8] mRNA showed a remarkably similar pattern of
bands compared to the AUG[YL8] mRNA (Fig. 1B, lanes 5–8).
A +15 nucleotide toeprint band was detected in the presence of
cycloheximide alone (lane 6) and its intensity was enhanced when
sparsomycin was also added to the reaction (lane 7). Again EDTA
inhibited the CUG initiation complexes confirming that the
toeprint required intact ribosomes (lane 8). Notably, in multiple
experiments, the CUG toeprint was reproducibly weaker than the
AUG toeprint representing ,18–25% of the intensity of the AUG
toeprint (Fig. 1C).
The location of the toeprint, 15–17 nucleotides downstream of
the initiation codon, indicates that the first aminoacyl-tRNA,
usually Met-tRNAi
Met, is placed in the P site of the ribosome in
contrast to the A site which is the first point of entry for all other
aminoacyl-tRNAs [19]. We conclude that ribosomal initiation
complexes can be assembled at the cryptic CUG initiation codons
at the same location as the canonical AUG initiation codons with
the tRNA positioned in the P site of the ribosome.
Ribosomal binding to the CUG codon occurs during
initiation
Ribosomes recognize mRNA codons during the initiation as
well as the elongation steps of protein synthesis [12,20]. However,
only the initiation step is strongly influenced by the nucleotides
surrounding the initiation codon [21]. To assess whether the
ribosomal binding to the CUG codon was due to the initiation
step, we carried out toeprint analysis with mRNAs containing
CUG codons with varying nucleotide contexts. We used mRNA
containing the AUG initiation codon as a positive control and
compared it with mRNAs containing a CUG codon in an
‘‘Excellent’’ (UCGACCCUGA) versus a ‘‘Poor’’ context
(GCGUCCCUGA). These nucleotide sequences were previously
identified in a screen for optimal initiation context for the CUG
initiation codon [10]. Compared to the strong toeprint band at
+15–17 nucleotides with the AUG codon and a weaker band with
the CUG codon in an ‘‘Excellent Kozak’’ context, a toeprint band
was not detected when the CUG was in a ‘‘Poor Kozak’’ context
(Fig. 2A, CUG Poor). These changes in the intensity of the CUG
toeprint by the Kozak context indicate that the CUG codon is
involved in the initiation step.
To further establish the impact of Kozak context on CUG
initiation, we transfected the same mRNAs into L-cell fibroblasts
expressing the K
b MHC I. Peptide presentation on the cell surface
was measured using the BCZ103 hybridoma, which is specific for
K
b bound LYL8 or the MYL8 peptides [8]. Robust T cell
activation was observed with the AUG[YL8] mRNA but not with
the CCC[YL8] mRNA showing that the AUG initiation codon in
the same ‘‘Kozak’’ context as CUG was efficiently used in
translation (Fig. 2B, top panel). In contrast, the BCZ103
hybridoma responded to cells transfected with the CUG[YL8]
mRNA, but only when the CUG was in an ‘‘Excellent Kozak’’
context (Fig. 2B, lower panel). Changing the CUG context to a
‘‘Poor Kozak’’ context diminished the level of antigen presentation
to almost that of the CCC[YL8] background. Note that
measurement of peptide presentation with cells transfected with
mRNA instead of cDNA constructs also rules out potential
variables such as transcription, splicing and mRNA export. We
conclude that differences in toeprint intensity in vitro as well as the
amount of translated products produced in living cells are
consistent with recognition of the CUG codon in the decoding
center of the ribosomal P site during initiation.
Next, we characterized ribosomal initiation at the CUG codon
for the key mediators that determine the specificity of this step; the
small and the large ribosomal subunits and the initiator tRNA.
CUG recognition requires 59 cap and GTP hydrolysis but
is independent of Met-tRNAi
Met
Prior to scanning for the initiation codon, conventional, but not
IRES-mediated, translation requires that ribosomes and initiation
factors first bind to the 59 m
7G cap structure that is present in all
eukaryotic mRNAs [12]. To assess directly whether CUG bound
ribosomes required binding to the 59 cap, we carried out toeprint
analysis in the presence of m
7GTP cap analog which competes for
binding to the cap binding protein, eIF4E. Upon addition of
mRNA, toeprints at both the AUG and CUG start codons were
strongly inhibited (Fig. 3A), indicating that ribosomes recognizing
the CUG as well as AUG initiation codons utilize the cap structure
at the 59 end of mRNAs. Taken together with the ability of stable
hairpins to inhibit pMHC I presentation efficiency shown in
functional assays [10], this result shows that initiation at CUG start
codons, unlike IRES mediated initiation, requires linear scanning
of the 59 mRNA sequence beginning at the 59 cap.
Next, we assessed whether GTP hydrolysis promoted the
assembly of complete ribosomal initiation complexes at the CUG
codon. In the absence of GTP hydrolysis, the 60S ribosomal
subunit does not assemble on 48S pre-initiation complexes which
contain the small 40S ribosomal subunit, several initiation factors
and Met-tRNAi
Met bound at the AUG start codon [12]. These
48S pre-initiation complexes lacking the 60S subunit accumulate
and produce toeprints like those obtained from the complete
initiation complexes with both the small and large ribosomal
subunits [22]. When the non-hydrolyzable GTP analog, GMP-
PNP, was included in the toeprinting reactions, we observed an
accumulation of pre-initiation complexes at both AUG and CUG
start codons (Fig. 3B). Thus, initiation at the CUG codon is
similar to the AUG codon in its requirement for GTP-hydrolysis
and is consistent with assembly of a pre-initiation complex.
The formation of a 48S pre-initiation complex in turn requires
the binding of 40S small ribosomal subunits loaded with initiation
factors and Met-tRNAi
Met. Loading of Met-tRNAi
Met onto 40S
subunits requires methionyl-tRNA synthetase to provide a
Initiating Cryptic Translation
PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3460dedicated pool of Met-tRNAi
Met for AUG initiation [23].
Inhibitors of methionyl-tRNA synthetase block initiation at
AUG start codons with Met-tRNAi
Met because they inhibit
aminoacylation of tRNA with methionine [24]. We used
methionine sulfamide (Met-sulfamide), a synthetic methionyl-
tRNA synthetase inhibitor in the AUG versus CUG toeprint
assay. Initiation on the AUG[YL8] mRNA, as seen by the toeprint
at +15–17 nt, was inhibited in a dose-dependent manner
(Fig. 3C,E). In contrast, the toeprint on CUG[YL8] mRNA
was relatively resistant to Met-sulfamide (Fig. 3C,E). As a
negative control, toeprints at both AUG and CUG mRNAs were
unaffected in the presence of phenylalanine-sulfamide (Phe-
sulfamide), a phenylalanyl-tRNA synthetase inhibitor (Fig. 3D).
Thus, a portion of CUG-specific initiation complexes can
assemble in the absence of Met-tRNAi
Met suggesting that a
different aminoacyl-tRNA is present in the ribosomal P site. This
result is in complete agreement with previous findings that CUG
can be decoded with a leucine residue [8,9,10].
Edeine inhibits AUG but not CUG initiation
Methionine-independent initiation at the CUG codon suggested
that it may be possible to further distinguish the recognition of
non-AUG versus AUG initiation codons with protein synthesis
inhibitors. Edeine is a peptide antibiotic which inhibits translation
in all organisms because it binds to the small 40S ribosomal
subunit and disrupts the proper placement of initiator Met-
tRNAi
Met within the P site of the ribosome (Fig. S1) [25]. Notably,
translation via the CrPV IRES is resistant to edeine, consistent
with Met-tRNAi
Met-independent initiation [15,26]. To assess
potential differences in ribosomal recognition of AUG versus the
non-AUG initiation codon, CUG, we carried out toeprint analysis
in the presence of edeine. As expected, the AUG-specific toeprint
was almost completely inhibited in the presence of edeine
(Fig. 4A). In contrast, edeine had little effect on the CUG
toeprint. To further confirm the differential effect of edeine on
CUG initiation, we tested a range of edeine concentrations in the
toeprint analysis and also included the CrPV mRNA as an edeine-
resistant control (Fig. 4B). Again, in contrast to the toeprints at
the AUG codon, the intensity of toeprints at the CrPV IRES as
well as the CUG mRNA was not reduced but was even enhanced
with increasing edeine concentration (Fig. 4B,C). We chose to
compare CrPV IRES to CUG initiation since CrPV initiation
complexes are known to be resistant to edeine, a universal
inhibitor of translation initiation. These results are consistent with
Figure 2. Initiation at the CUG codon depends upon the Kozak context in vitro and in vivo. (A) Toeprinting with AUG[YL8] and CUG[YL8]
mRNAs in either an ‘‘Excellent Kozak’’ (UCGACC[CUG]A) or a ‘‘Poor Kozak’’ context (GCGUCCCUGA). The toeprints at +15–17 nucleotides
downstream of the AUG or CUG start codons are indicated. The bar graph below shows the intensity of toeprints in arbitrary Phosphoimager units
(AU). The data shown are representative of three independent toeprinting experiments. (B) The mRNAs used for toeprinting in (A) and an mRNA with
the CCC initiation codon as a negative control, were transfected into K
b-L cells. Three hours later the presentation of peptide-K
b complexes on the cell
surface was measured using the LYL8-K
b or MYL8-K
b specific BCZ103 hybridoma. The b-galactosidase activity induced in the activated T cell
hybridoma was measured using the substrate chlorophenol red-b-D-galactopyranoside, which yields a colored product with an absorbance at
595 nm.
doi:10.1371/journal.pone.0003460.g002
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alternate initiation mechanism that did not utilize Met-tRNAi
Met
in the P site of the ribosome.
Next, we analyzed the reaction mixtures by sucrose-gradient
fractionation to confirm that the initiation complexes contained
both 40S and 60S ribosomal subunits. Fractions were collected
after ultracentrifugation of the initiation complexes layered onto
10–40% sucrose gradients. The absorbance of the individual
fractions obtained with AUG[YL8] or CUG[YL8] mRNAs,
shown in a representative experiment, revealed several distinct
peaks with a maxima in fractions 21–26 for AUG[YL8]
(Fig. 5A). We extracted RNA from these as well as surrounding
fractions and analyzed the material on denaturing RNA gels
(Fig. 5B). Bands corresponding to both 18S and 28S RNA were
observed in an ethidium bromide-stained gel, with fractions 23–
25 containing the highest amounts. The same fractions also
contained the largest amount of mRNA when analyzed by a
Northern blot (see methods for details). Thus, fractions 23–25
representing the predominant RNA absorbance contained the
40S and 60S ribosomal subunits as well as mRNA. However, in
the presence of edeine the intensity of the AUG[YL8] mRNA
band in the corresponding fractions was markedly reduced
(Fig. 5B,C). Thus, edeine disrupted interactions between
initiation complexes and the AUG mRNA. In contrast, when
edeine was included in the reaction mixtures with the
CUG[YL8] mRNA, there was little, if any, change in the
fractions containing the mRNA (Fig. 5B,C).
To further confirm the differences in edeine sensitivity between
ribosomes bound to either the AUG or CUG start codons, we used
mRNA labeled directly with [a
35S]-CTP (Fig. 5D, left panel).
After fractionation of sucrose-density gradients, labeled AU-
G[YL8] mRNA was found in dense fractions (fractions 12–14)
representing initiation complexes while a large amount of the total
mRNA was free of ribosomes and present in the lighter fractions
(fractions 3–6). In the presence of edeine, the initiation complex
peak (mRNA+ribosomes) was reduced and there was a concom-
itant increase in the amount of free mRNA. In contrast, only a
small difference in the initiation complex and free mRNA peaks
was observed with CUG[YL8] mRNA (Fig. 5D, right panel).
Thus, the assembly of AUG versus CUG initiation complexes can
be distinguished by their sensitivity to edeine. Furthermore, this
result shows that the difference in codon recognition is mediated
through interactions within the decoding center of the 40S
subunit.
Figure 3. CUG recognition requires 59-cap and GTP hydrolysis but is independent of Met-tRNAi
Met. (A) Toeprint analysis of AUG[YL8]
and CUG[YL8] mRNAs in the presence of translation initiation inhibitors cycloheximide and sparsomycin and the 59-cap m
7GTP analog (1 mM). (B)
Toeprint analysis in the presence of the non-hydrolyzable GTP analog, GMP-PNP (0.4 mM). Cycloheximide and sparsomycin were not included in this
experiment because GMP-PNP inhibits large ribosomal subunit assembly on the pre-initiation complexes. (C) Methionine-sulfamide (Met-sulfamide)
inhibits toeprints in a dose-dependent manner on AUG[YL8] mRNA, but not CUG[YL8] mRNA. Met-sulfamide (along with cycloheximide and
sparsomycin) were added during the 5 min preincubation prior to adding mRNA. (D) Phenylalanine-sulfamide (Phe-sulfamide) does not alter
toeprints on either AUG or CUG mRNAs. Phe-sulfamide was added to toeprint reactions as carried out for Met-sulfamide described above. (E) Relative
toeprint intensity is % of untreated sample from (C) with data from three independent experiments and from (D) with data from two independent
experiments (mean+/2standard error).
doi:10.1371/journal.pone.0003460.g003
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Although edeine distinguished the initiation complexes
assembled at the AUG versus CUG codons, its various other
side-effects preclude its use in living cells (data not shown).
Therefore, we used the toeprinting assay to test a panel of
translation inhibitors that distinguish conventional versus IRES
mediated translation [27,28]. Among the several compounds
tested (data not shown), bruceantin, an irreversible inhibitor of
initiation [28] which binds the large ribosomal subunit [29], was
similar to edeine because it inhibited the AUG but not the CUG
toeprint (Fig. 6A and Fig. S1). In contrast, and as a negative
control, neither the AUG nor the CUG toeprint was affected by
emetine, a potent elongation inhibitor (Fig. 6B). To directly
assess the effect of bruceantin on protein translation in vitro,w e
generated luciferase (Luc) constructs with AUG, CUG, and
CCC initiation codons and translated these mRNAs in rabbit
reticulocyte extract (Fig. 6C). Measurement of the translated
material showed that the amount of CUG-initiated Luc was
approximately ,10% of AUG-initiated Luc while the CCC
codon did not support detectable translation. Notably, low
nanomolar concentrations of bruceantin inhibited the translation
of AUG-Luc more strongly than that of CUG-Luc (Fig. 6D).
Thus, translation of AUG versus CUG-initiation codons in vitro
could be distinguished by both edeine and bruceantin.
Bruceantin distinguishes the presentation of AUG- versus
CUG-initiated peptides
In contrast to edeine, bruceantin was relatively non-toxic to
tissue culture and primary cells (data not shown), making it
possible to assess the effect of bruceantin on pMHC I translated
via AUG versus CUG codons in living cells. We first used spleen
cells from a mouse with a transgene encoding a conventional
AUG-initiated AUG[WI9] and cryptic CUG[YL8] peptides [9].
The cells were first washed with mild acid to remove pre-existing
surface pMHC I complexes and incubated with bruceantin during
a 3 h recovery. As little as 10 nM bruceantin inhibited peptide
supply as judged by expression of surface K
b MHC I molecules
(data not shown). The spleen cells were also co-cultured with the
WI9/D
b specific 11p9Z hybridoma [9], or the LYL8/K
b specific
BCZ103 T cell hybridoma. The presentation of WI9 peptide
encoded in the conventional AUG initiation context, despite being
expressed at approximately one hundred fold higher level [9], was
inhibited in the presence of bruceantin while that of CUG-
initiated LYL8 peptide was unaffected (Fig. 7A). Thus, bruceantin
differentially affected the expression of AUG versus CUG
translation in primary spleen cells.
To rule out potential complications due to transcription of the
transgene, we transfected K
b L-cells with mRNAs encoding the
AUG[YL8] or the CUG[YL8] peptides. After allowing 3 hours for
Figure 4. Edeine inhibits AUG but not CUG toeprints. (A) Toeprints of mRNAs with the indicated initiation codons in the absence or presence
of edeine (2 mM). The toeprints at +15–17 nucleotides downstream of the AUG or CUG start codons are boxed. Data are representative of five
independent experiments. Sequencing lanes shown are for the CUG[YL8] mRNA. (B) Edeine enhances the toeprints on the cricket paralysis virus
(CrPV) IRES mRNA in a dose-dependent manner. (C) Relative toeprint intensity (% of untreated sample) of the AUG[YL8], CUG[YL8], and CrPV IRES
mRNAs in the presence of indicated doses of edeine (mean+/2standard error). The intensity of the toeprint in the absence of edeine is set at 100%.
Data are from two independent experiments.
doi:10.1371/journal.pone.0003460.g004
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another 3 hours and then assayed for pMHC I expression with the
MYL8 or LYL8/K
b-specific BCZ103 T cell hybridoma (Fig. 7B).
The response of the BCZ103 hybridoma to peptide derived from
the potent AUG[YL8] mRNA precursor was reproducibly lower
after bruceantin treatment while there was no detectable
difference in the presentation of peptide derived from the
CUG[YL8] mRNA. Because T cell responses to cells expressing
minigene constructs can be saturated, we directly measured the
translated material in peptides extracted from bruceantin treated
cells. Again, the antigenic activity in extracts of AUG mRNA
transfected cells was markedly reduced in the presence of
bruceantin (Fig. 7C). In contrast, despite the weaker response to
cells transfected with CUG mRNA (Fig. 7C), there was no
detectable difference in the peptide activity in cell extracts. Thus,
differential sensitivity to bruceantin indicates that CUG initiation
also differs from canonical initiation at the peptidyl transferase
center of the large ribosomal subunit.
T a k e nt o g e t h e rw i t ht h ein vitro toeprint and translation
assays, these cellular assays show that initiation at the cryptic
CUG codon can be distinguished from initiation at the
canonical AUG codon. Because edeine and bruceantin exert
their effects on the P site of the small and large ribosomal
subunits respectively, distinct mechanisms are used to decode
these initiation codons.
Discussion
We show here that the translation mechanism for synthesizing
cryptic peptides for presentation by MHC I is mediated through
recognition of non-AUG initiation codons by ribosomes during the
initiation step. Remarkably, the initiation mechanism for cryptic
translation at CUG codon in these model antigens differs from
that for conventional AUG codons by its sensitivity to inhibitors
which affect interactions within the peptidyl transferase and
decoding centers of the ribosomal P site. These findings provide
insights into the mechanisms of cryptic translation at non-AUG
start codons and suggest it could be used to regulate the peptide
repertoire presented by MHC I molecules.
A large fraction of peptides presented by MHC I on the cell
surface is derived from newly synthesized polypeptides [30,31].
Beginning the antigen presentation pathway with newly synthe-
sized material is particularly advantageous for immune surveil-
lance of virus infected cells. The display of actively synthesized
proteins as pMHC I allows CD8
+ T cells to potentially detect
intracellular viruses as soon as viral mRNAs are translated [32].
Furthermore, protein synthesis could be linked to generation of
pMHC I in normal uninfected cells as well because the antigen
presentation pathway is constitutively active in all cells.
The toeprinting method allows direct assessment of ribosomal
binding to the mRNA obviating the complexities of various post-
Figure 5. Edeine inhibits AUG- but not CUG-specific ribosomal initiation complexes. Ribosomes bound to the AUG[YL8] or CUG[YL8]
mRNAs were fractionated on 10–40% sucrose gradients in the absence or presence of edeine (2 mM). (A) The ultraviolet light absorbance is shown for
each fraction for reactions with the AUG[YL8] mRNA. (B) Total RNA from fractions 21–29 of AUG[YL8] and 26–33 of CUG[YL8] samples with or without
edeine was fractionated on 1% formaldehyde gels. For each fraction, the ribosomal RNA from the large and small ribosomal subunits was visualized
with ethidium bromide (EtBr) and the mRNA was detected by Northern blot. (C) mRNA amounts measured by pixel intensity of peak fractions of AUG
versus CUG reactions in (B) is shown in arbitrary units (AU). (D) Sucrose gradient fractionation of AUG[YL8] and CUG[YL8] initiation complexes was
carried out as in (A) except the mRNA was directly labeled with [a
35S]-CTP and radioactivity (CPM, counts per minute) in each fraction was
determined by liquid scintillation. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0003460.g005
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toeprints, judged by the size of the reverse transcriptase product,
reveal not only whether ribosomes are specifically bound to a
particular sequence in the mRNA, but also the location of
ribosomes at a single nucleotide resolution. With mRNAs
encoding antigenic peptides, we determined that the toeprint at
the CUG codon was identical in size to that of the AUG codon. In
agreement with the low levels of the cryptic pMHC I expression,
the amount of the CUG toeprint product was about 18–25% that
of the AUG product (Fig. 1). Thus, the cryptic CUG codon in the
mRNA was capable of not only engaging ribosomes but did so at
the same location as the conventional AUG codon.
The exact location of the ribosome on the mRNA in the
initiation step is critical because it determines the subsequent
translational reading frame. The small 40S ribosomal subunit
preloaded with initiator Met-tRNAi
Met scans in the 59 to 39
direction until an initiation codon, usually AUG, is found in a
suitable nucleotide context [34,35,36]. The ribosome becomes
functional when the 60S ribosomal subunit assembles with the 40S
subunit bound to the initiation codon. At this juncture, Met-
tRNAi
Met occupies the P site of the ribosome and the
appropriately charged aminoacyl-tRNA specific for the next
codon is recruited into the A site (Fig. S1). Remarkably, the
CrPV IRES can direct initiation in the A site of the ribosome
because toeprints were observed with GCU, a non-AUG codon
encoding alanine, positioned in the A site, not the P site [15].
Thus, the CrPV IRES is similar to mRNAs used here because
both use non-AUG codons and are decoded as non-methionine
residues. Despite this similarity, ribosomes bound the CUG codon
at the same location as the AUG codon. Therefore, translational
initiation at the CUG codon does not involve a CrPV IRES-like
activity and is similar to initiation at the conventional AUG codon.
The similarity between conventional AUG and CUG recognizing
ribosomes was further supported by the positive influence of the
Figure 6. The toeprint and translational activity of CUG initiation codon is resistant to bruceantin. (A) The translation inhibitor
bruceantin inhibits AUG toeprints, but not CUG toeprints in a dose-dependent manner. Bruceantin was preincubated with translational extract prior
to adding the mRNA with the indicated AUG or CUG initiation codons. Relative toeprint intensity (% of untreated sample) represent three
independent experiments (mean+/2standard error). (B) The AUG as well as CUG toeprints are insensitive to emetine, an elongation inhibitor. The
data are representative of three independent experiments. (C)[
35S]-Methionine labeled translated products of firefly luciferase (Luc) mRNAs with
AUG, CUG, and CCC initiation codons in vitro. The translation products were resolved on 4–10% SDS-PAGE gel. Position of the 61 kD luc product is
indicated by an arrow. Data are representative of three independent experiments. (D) Translation of AUG-Luc, but not CUG-Luc is inhibited by
bruceantin in a dose-dependent manner. Indicated concentrations of bruceantin were added to the translation mix prior to the addition of mRNA.
The luciferase activity was determined using a luminometer. Luciferase activity (% of untreated sample) is from two independent experiments
(mean+/2standard error).
doi:10.1371/journal.pone.0003460.g006
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intensity as well as the expression of the CUG derived pMHC I on
the cell surface (Fig. 2).
Despite their similarities, the ribosomes recognizing the CUG
initiation codon differed from those recognizing the AUG codon
at both the large and small ribosomal subunit level. The MetRS
inhibitor, methionine-sulfamide, reduced the binding of ribosomes
at the AUG codon, but had relatively small effect on ribosomes
binding the CUG codon (Fig. 3). This suggests that a significant
fraction of 40S ribosomes which recognize CUG are either devoid
of Met-tRNAi
Met or are preloaded with a different initiator-tRNA.
The most obvious candidate for this function would be a leucyl-
tRNA because the CUG start codons of antigenic peptides as well
as human trypsinogen can be decoded with leucine [8,9,10,37].
To further distinguish the ribosomes recognizing the CUG
codon from conventional ribosomes we tested small molecule
inhibitors in the toeprint assay. Edeine, a bacterial antibiotic
isolated from Bacillus brevis [38], inhibits recognition of AUG start
codons in mRNA by the small ribosomal subunit and profoundly
inhibited the AUG toeprint in a dose-dependent manner (Fig. 4).
Remarkably, the toeprint on the CUG codon was resistant to
edeine. Structural studies have shown that edeine binds to the 40S
ribosomal subunit and interferes with recognition of the AUG
codon by Met-tRNAi
Met [25,39]. Insensitivity of ribosomal
recognition of CUG but not AUG to edeine is therefore, entirely
consistent with the distinction between these ribosomes also seen
with methionine-sulfamide.
Bruceantin, another small molecule like edeine, also inhibited
the toeprints at the AUG, but not the CUG codon (Fig. 6,7).
Bruceantin, isolated from the Ethiopian tree Brucea antidysenterica
Mill. (Simaroubaceae) [40], is an irreversible inhibitor of
translation initiation [28]. Bruceantin binds the large ribosomal
complex at highly conserved nucleotides within the P site of the
ribosome where initiator Met-tRNAi
Met binds [29]. Importantly,
bruceantin inhibited AUG, but not CUG initiated translation of
antigenic precursors in murine fibroblasts as well as normal spleen
cells (Fig. 7). These observations show that the synthesis of
polypeptides initiated by recognition of the CUG codon is
mediated by initiation complexes which differ from those that
initiate at the conventional AUG codon. Furthermore, because
bruceantin binds nucleotides in the P site of the large ribosomal
complex [29], and discriminates CUG from AUG initiation
suggests that unique structural features distinguish these initiation
complexes. This is also consistent with insensitivity of CUG
binding ribosomes to edeine which further implicates the P site of
the ribosome as the region responsible for distinguishing cryptic
from canonical translation.
Interestingly, ribosomal heterogeneity has been invoked as a
potential mechanism to explain complexities of biological
phenomenon. For example, the ribosomal filter hypothesis of
Mauro and Edelman suggests that interactions between mRNA
sequences and heterogeneous ribosomes exerts a level of
translational control during differentiation and development
[41]. More recently, the functional analysis of duplicated genes
Figure 7. Generation of pMHC I complex derived from the AUG but not CUG mRNA is inhibited by bruceantin. (A) Primary cells from a
transgenic mouse are sensitive to bruceantin inhibition from AUG but not CUG start codons. The transgene encodes two peptides: WI9 initiated with
an AUG and LYL9 initiated with CUG located in the 39 untranslated region directly downstream from WI9. Spleen cells were washed with mild-acid
and allowed to recover for 3 hours in medium+DMSO or in the presence of 25 nM bruceantin. Peptide translation is measured with the 11p9Z and
BCZ103 hybridomas for AUG and CUG initiation, respectively. (B) The K
b-L cells were transfected with mRNAs encoding AUG[YL8] or CUG[YL8], and
CCC[YL8] as a negative control. After three hours to allow mRNA entry and expression, the cells were incubated with 100 nM bruceantin for another
three hours. The indicated numbers of cells were then used as antigen presenting cells for the BCZ103 hybridoma specific for K
b-bound LYL8 or the
MYL8 peptides. (C) Antigenic peptides in extracts of mRNA transfected cells in the absence or presence of bruceantin. After transfection, K
b-L cells
were acid-washed and allowed to recover for 3 hours in medium+DMSO or in the presence of 100 nM bruceantin. Peptides were extracted from the
cells by homogenizing in 10% acetic acid, dried and antigenic activity measured with the BCZ103 hybridoma and K
b-L cells as APC. The data are
representative from four independent experiments.
doi:10.1371/journal.pone.0003460.g007
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non-redundant roles in mRNA localization and translation [42].
Finally, and pertinent to antigen presentation, Yewdell and
Nicchitta have argued in favor of an ‘‘immunoribosome’’,
dedicated to the efficient supply of polypeptides for presentation
by MHC I [18]. The structural differences between all these
subsets of ribosomes in eukaryotic models, as well as the
mammalian ribosomes capable of distinguishing the AUG and
CUG initiation codons described here remain unknown. Given
the differential sensitivity of ribosomes in this system to edeine and
bruceantin which directly bind ribosomal RNA [25], it is possible
that they could be distinguished by the structural features of a
unique initiator tRNA and/or ribosomal RNAs. The recent
discovery of ribosomes containing mutant RNA which fail to
translate IRES-containing mRNAs in X-linked dyskeratosis
congenita is also consistent with this notion [43].
In conclusion, we have shown that initiation at the CUG codon
for generating cryptic pMHC I can differ from initiation at the
conventional AUG codon. While CUG initiation shares some
similarities with AUG initiation, it diverges in its requirements and
sensitivity to inhibitors which act within the initiation P site of the
ribosome. Such cryptic initiation events could provide an
important source of peptides for antigen presentation during viral
infection or cellular stress when conventional translation mecha-
nisms are subverted [44].
Methods
Experimental Procedures
Plasmid constructs. The cDNA constructs used for
toeprinting and transfections were based upon those used earlier
in functional antigen presentation assays [10]. The ‘‘Excellent
Kozak’’ CTG[YL8] in the pcDNA1 vector (Invitrogen, Carlsbad,
CA, U.S.A.): 59- TGTGTAGTCGACCCTGACCTTCAACTA
CCGGAATCTCTAG-39. The ATG[YL8] and CCC[YL8]
constructs were identical in length and sequence to CTG[YL8]
using the Sal I/Xba I sites from Excellent Kozak CTG[YL8]
above; ATG[YL8]: 59-GTCGACCATGACCTTCAACTACC
GGAATCTCTAGA-39 and CCC[YL8]: 59-GTCGACCCCCA
CCTTCAACTACCGGAATCTCTAGA-39. Firefly luciferase
constructs (Luc) used for in vitro translation were prepared from
Promega’s T7 Luciferase Control Plasmid (Promega, Madison,
WI, U.S.A.) by site-directed mutagenesis (Stratagene, La Jolla,
CA, U.S.A.) of the ATG start codon as well as the upstream
sequence to an ‘Excellent Kozak’ sequence: 59-TCGACCCCC-39,
59-TCGACCATG-39, and 59-TCGACCCTG-39, respectively.
Cricket Paralysis Virus IRES-Firefly luciferase was in the
pGEM-3 vector (CrPV-Luc) and was a kind gift from Peter
Sarnow (Stanford University).
Synthesis of mRNAs. Plasmid DNA was linearized with Hpa I
for pcDNA1 plasmids, Afe I for Luc plasmids, and Nae I for CrPV-
Luc were used as templates for transcription by T7 RNA polymerase
(RiboMAX Large Scale mRNA production system-T7; Promega or
mMessage mMachine T7; Ambion, Austin, TX, U.S.A.) to yield
CCC-, AUG-, CUG[YL8], CCC-, AUG-, CUG-Luc, and CrPV-
Luc mRNAs,respectively. Transcription reactions contained m
7GTP
cap analog (Promega or Ambion) to yield naturally capped mRNAs.
The Poly(A) Tailing Kit (Ambion) was used to add poly(A) tails onto
mRNAs for cell transfections. Radiolabeled mRNA was prepared by
including [a
35S]-CTP (1250 Ci/mmole; Perkin Elmer, Waltham,
Massachusetts, U.S.A.) in the transcription reaction.
Primer extension ‘toeprinting’ assay of initiation
complexes. The 59-end of the DNA oligonucleotide 59-
GTCACACCACAGAAGTAAGG-39 used as the reverse primer
was labeled with T4 polynucleotide kinase and [c-
32P]ATP (3000
Ci/mmol; Perkin Elmer). This primer is complementary to the
mRNA at position +76 from the AUG/CUG start codons in the
pcDNA1 vector. For toeprinting with CrPV-Luc, we used the
oligonucleotide 59-GCCTTATGCAGTTGCTCTCC-39 which is
complementary to the mRNA at position +86 from the GCU
initiation codon. For toeprinting with emetine (Sigma) and
bruceantin (obtained from the NCI/DTP Open Chemical
Repository http://dtp.nci.nih.gov; NSC165563), the non-
radioactive primer 59-Alexa750 -GTCACACCACAGAAGTAA
GG-39 (Invitrogen) was employed. m
7GTP cap analog was
obtained from Promega and GMP-PNP was obtained from
Sigma. Methionine- and phenylalanine-sulfamide were
synthesized according to previously published methods [45].
The ribosome binding reactions utilized micrococcal nuclease-
treated rabbit reticulocyte lysate (Flexi-rabbit from Promega).
Reaction mixtures were assembled on ice in a total volume of
30 mL containing 50% (v/v) reticulocyte lysate, 500 mg/mL
cyclohexmide, 200 mM sparsomycin, 2 mM DTT, 100 mM
KCl, 0.5 mM MgOAc2, and any additional test compounds (e.g.
edeine), and pre-incubated at 30uC for 5 min to allow the drugs to
interact with the translational machinery. Template mRNA
(0.5 mg/reaction) and 20 mM amino acids were added to allow
initiation complex assembly at 30uC for 10 min.
The reverse transcriptase reaction was carried out in a total
volume of 45 mL containing the entire ribosome binding reaction,
50 mM Tris-HCl (pH 8.3), 50 mM KCl, 10 mM MgCl2, 0.5 mM
spermidine, 10 mM DTT, 500 mM of each dNTPs, 3.1 pmol
32P-
primer (or 3.1 pmol Alexa750-primer for bruceantin (NCI) and
emetine (Sigma)), and 10 U Avian Myeloblastosis Virus Reverse
Transcriptase (RT, Promega). Reactions were incubated at 30uC
for 35 min. Primer extension products were extracted by adding
an equal volume pf phenol:CHCl3 followed by precipitation with
1/10 vol. 3 M NaOAc (pH 5.2) plus 2.5 vol. ethanol. cDNAs were
mixed with 40% formamide, 8 mM EDTA and heated to 95uC
for 5 min before layering onto 8% polyacrylamide sequencing gel.
For reference, RNA sequencing ladders were generated by primer
extension with dideoxynucleotides using AMV. Dried gels were
exposed on a PhosphoImager screen and analyzed using a Storm
PhosphoImager (Molecular Dynamics). Gels loaded with
Alexa750-cDNAs were visualized using an Odyssey Infrared
Imaging System (LI-COR Biosciences, Lincoln, Nebraska U.S.A).
Sucrose gradient fractionation and Northern blot analysis
of initiation complexes. Reactions for sucrose gradient
fractionation were the same as for toeprinting except they were
scaled up to 100 mL and contained 5 mg mRNA. After initiation
complex assembly at 30uC for 10 min, reactions were diluted with
100 mLo f2 6sample dilution buffer for a final concentration of
20 mM HEPES-KOH (pH 7.4), 100 mM KCl, 6 mM MgCl2,
2 mM DTT, 500 mg/mL cycloheximide and brought to 4uCo n
ice for 5 min prior to centrifugation using a SW-41 rotor
(Beckman) for 2.5 h (39,000 rpm) at 4uC in 10–40% sucrose
gradients containing 20 mM HEPES-KOH (pH 7.4), 100 mM
KCl, 6 mM MgCl2, 2 mM DTT, 100 mg/mL cycloheximide.
Gradients were manually fractionated (0.2 mL fractions: 32
fractions/gradient) and a portion was used for absorbance
determination at 260 nm. RNA was extracted from the
remaining portion (,180 mL) of each fraction by addition of
200 mL of guanidine thiocyanate buffer (4 M guanidine
thiocyanate, 25 mM sodium citrate, 0.5% N-lauryl sarcosine,
5 mM EDTA, and 0.1 b-mercaptoethanol) and 125 mLo f
saturated phenol. The samples were periodically rotated at RT
for 15 min, followed by addition of 100 mL of CHCl3 and the
samples were mixed and centrifuged at 5,0006g for 10 min at
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plus 2 vol. ethanol, re-suspended in nuclease-free water and
combined with RNA loading buffer (32 mM MOPS (pH 7.0),
1.6 mM EDTA (pH 8), 0.54% formaldehyde, 4% glycerol, 6.2%
formamide, 10 mg/mL ethidium bromide), heated to 65uC for
10 min, and loaded onto a 1% formaldehyde gel (Ambion). RNA
was transferred to a Hybond-XL membrane (GE Healthcare Life
Sciences, Piscataway, NJ, U.S.A.) and probed with cDNA
prepared from priming CUG[YL8] mRNA with the
oligonucleotide 59-Alexa750 -GTCACACCACAGAAGTAAGG-
39 (Invitrogen) in 0.25 M sodium phosphate buffer (pH 7.2),
1 mM EDTA, 1% BSA, 7% SDS, containing 100 mg/mL
denatured salmon sperm DNA at 59uC. Blots were imaged on
an Odyssey Infrared Imaging System. Sucrose gradient
fractionation with radiolabeled mRNA was carried out as
described above except 1.5610
7 CPM of body-labeled [a
35S]-
CTP mRNA was added per 100 mL reaction. Fractions were
analyzed via liquid scintillation spectrometry.
In vitro translation. Translation reactions in a total volume
of 50 mL containing 70% (v/v) RRL, 100 mM KCl, 0.5 mM
MgOAc2,2 0mM amino acids, 40 U rRNasin (Promega) and test
compound in no more than 1% DMSO were pre-incubated at
30uC for 5 min prior to the addition of AUG-, CUG-, and CCC-
Luc mRNA and continued incubation for up to 1 h. A portion of
the translation mix was allowed to equilibrate to RT and Luc
activity was analyzed on a luminometer using Luciferase assay
reagent (Promega). Incorporation of [
35S]-Methionine into Luc
protein from AUG-, CUG-and CCC-Luc mRNA was carried out
as described above except each translation reaction contained
33 mCi of L-[
35S]-Methionine (.1000 Ci/mmol; Perkin-Elmer)
and 20 mM amino acids minus methionine (Promega). A portion
of the translation reaction was combined with SDS gel-loading
buffer (50 mM Tris-HCL (pH 6.8), 2% SDS, 0.1% bromophenol
blue, 10% glycerol, 100 mM dithiotheitol), heated to 95uC for
5 min, and resolved using 4–10% SDS-PAGE.
mRNA transfections and T cell assays. L-cell fibroblasts
expressing K
b and BCZ103 cells and their culture conditions have
been described [46]. Cells were plated the night before at
5610
5 cells/well for 6-well plates or 4610
6 cells/dish for 10 cm
dishes. The next day, poly(A) mRNA at 2 mg per well for 6-well
plates or 10 mg for 10 cm dishes was used for 3 h transfections using
TransMessenger Transfection Reagent (Qiagen, Valencia, CA,
U.S.A.) according to the manufactur’s recommendations. For
bruceantin treatment, cells were rinsed with 16 PBS and fresh
media containing bruceantin at the indicated dose was added for
another 3 h. For acid wash experiments, transfected cells were
treated with 0.131 M citric acid, 0.066 M NaH2PO4 pH 3.1 for
2 min, washed twice with 16 PBS, followed by addition of fresh
media containing bruceantin with a 3 h incubation. Cellviabilty was
was determined by subjecting treated or untreated cells to the
CellTiter 96 Aqeuous Non-radioactive Cell Proliferation Assay
(Promega) or by analysis of propidium iodide stained cells by flow
cytometry. Extracts were prepared by resuspending APCs in 10%
acetic acid and placed in boiling water for 10 min. Cell debris was
removed by centrifugation at 13,0006g for 15 min and samples
dried by vaccum centrifugation. Dried material was resupended in
16PBS containing 25 mg/mL phenol red and the pH adjusted to 7
with 0.1NNaOHand titratedin96-wellplates.APCswereadded at
5610
4 cells/per well together with 1610
5 BCZ103 Lac Z-inducible
T hybridoma [46]. The pMHC I induced accumulation of
intracellular b-galactosidase in the hybridoma, was measured with
the conversion of the substrate chlorophenol red-b-D-
galactopyranoside with a 96-well plate reader at 595 nm and
655 nm as the reference wavelength [47]. Spleens from C57BL/6J
(B6) mice were used to determine the effect of bruceantin on peptide
supply. Transgenic mice have been described [9]. Spleen cells were
treated with Puregene RBC Lysis Solution (Gentra Systems) to lyse
red blood cells and subjected to mild acid wash as described above.
After washing twice with 16PBS, spleen cells were resuspened at
2610
6 cells/mL and treated with either DMSO or 25 nM
bruceantin for 3 h. To determine the effet of bruceantin on
peptide supply, spleen cells were stained with FITC a-mouse K
b
Mab (AF6-88.5) or FITC mouse IgG2a, as an isotype control (BD
Pharmingen). Stained cells were analyzed by flow cytometry with
FlowJo data analysis software. For T cell assays, expression of the
WI9/D
b or LYL8/K
b complexes was assessed by lacZ assays as
described earlier [9].
Supporting Information
Figure S1 Primer extension inhibition analysis ‘toeprinting’ on a
model mRNA. Ribosomes in rabbit reticulocyte lysate were
allowed to undertake the translation initiation step on natural
globin mRNA but without translating the message. Initiation
complexes containing ribosomes and other factors are stalled at
the AUG start codon by the elongation inhibitors cycloheximide
(CHX) and sparsomycin (SPR), which bind to the 60S ribosomal
subunit and hence do not interfere with the initiation steps. The
location of the ribosomal initiation complexes was identified by
extending a [32P]-labeled complementary 39 primer with reverse
transcriptase (RT), up to the leading edge of the ribosome, 15–17
nucleotides downstream of the AUG codon (RT Stop). The
resulting RT products were analyzed by gel-electrophoresis. The
size of the fragments was measured at a single nucleotide
resolution by comparison with sequencing reactions run on the
same gel. Red boxes in the sequencing lanes indicate the location
of the AUG codon and the toeprint at +15–17 nucleotides is
boxed. The band at the top of the gel represents the full-length RT
product up to the 59-end of the mRNA. Unincorporated primer
runs at the bottom of the gel. When edeine, an initiation inhibitor,
is included in the toeprinting reaction along with cycloheximide
(CHX) and sparsomycin (SPR), the toeprint is no longer observed
and there is a concomitant increase in the intensity of the full-
length cDNA band. Edeine and bruceantin bind the small and
large ribosomal subunits, respectively.
Found at: doi:10.1371/journal.pone.0003460.s001 (0.74 MB TIF)
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